(Taken from application) The goal of this project is to carry out studies that will evaluate the hypothesis that abnormalities in signal transduction mechanisms, especially those involving metabolism of phospholipids and their component fatty acids are critically involved in the complex events comprising the pathogenesis of experimental diabetic neuropathy. The mechanism by which aldose reductase inhibitors and antioxidants, especially RRR -alpha-tocopherol (Vitamin E), exert their beneficial effects on diabetic nerve will also be studied.
The specific aims of this project are as follows: 1.Investigation of the possible relationship between arachidonic acid (AA) metabolism, the polyol pathway and antioxidant treatment in human primary and tumor-derived (NF1T) Schwann cell lines, as well as in primary neonatal rat and human fetal Schwann cells by examining the effects of aldose reductase and sorbitol dehydrogenase inhibitors as well as Vit E and N-acetylcysteine, on arachidonyl containing molecular species (ACMS) levels and arachidonate turnover. 2. Exploration of the mechanism underlying reduced ACMS levels and altered AA turnover in NF1T cells grown in elevated glucose by : a) measurement of free fatty acid and acyl CoA levels; b) assay of delta-6 desaturase activity; c) assay of PLA2 activity; d) determination of NADP+/NADPH ratio e) identification of AA metabolites i.e. prostaglandins and HETEs, released from the cells and the ability of the cells to synthesize these compounds. 3. Complementary experiments will be performed by feeding normal and streptozotocin -induced diabetic rats diets supplemented with : a) an aldose reductase inhibitor; b) Vit E ; c) both agents together ; d) a Vit E deficient diet. The effects of these dietary regimens on nerve ACMS, DAG levels and PKC activity will be assessed. These analyses will be correlated with morphological examination and nerve conduction velocity measurements. In addition it will determine whether ACMS levels are reduced in normal and transgenic mice that express human aldose reductase. 4. Investigations on the expression of several antioxidant enzymes in nerve and dorsal root ganglia from normal and STZ-induced diabetic rats with respect to their mRNA levels and protein, as well as enzyme activities. The enzymes will include Mn superoxide dismutase, glutathione peroxidase and catalase. The impact of Vit E supplementation and imposition of a Vit E deficiency on expression and activity of the enzymes will also be examined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030577-17
Application #
2900155
Study Section
Special Emphasis Panel (ZRG1-NLS-1 (01))
Program Officer
Jones, Teresa L Z
Project Start
1982-07-01
Project End
2002-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
17
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Houston
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
800771594
City
Houston
State
TX
Country
United States
Zip Code
77204
Konde, Viren; Eichberg, Joseph (2006) Myelin protein zero: mutations in the cytoplasmic domain interfere with its cellular trafficking. J Neurosci Res 83:957-64
Eichberg, Joseph (2002) Myelin P0: new knowledge and new roles. Neurochem Res 27:1331-40
Miinea, Cristinel; Kuruvilla, Rejji; Merrikh, Houra et al. (2002) Altered arachidonic acid biosynthesis and antioxidant protection mechanisms in Schwann cells grown in elevated glucose. J Neurochem 81:1253-62
Iyer, S; Bianchi, R; Eichberg, J (2000) Tyrosine phosphorylation of PNS myelin P(0) occurs in the cytoplasmic domain and is maximal during early development. J Neurochem 75:347-54
Nagaraja, S; Iyer, S; Liu, X et al. (1999) Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Br J Pharmacol 127:1099-104
Yorek, M A; Dunlap, J A; Manzo-Fontes, A et al. (1999) Abnormal myo-inositol and phospholipid metabolism in cultured fibroblasts from patients with ataxia telangiectasia. Biochim Biophys Acta 1437:287-300
Kuruvilla, R; Eichberg, J (1998) Depletion of phospholipid arachidonoyl-containing molecular species in a human Schwann cell line grown in elevated glucose and their restoration by an aldose reductase inhibitor. J Neurochem 71:775-83
Doss, D J; Kuruvilla, R; Bianchi, R et al. (1997) Effects of hypoxia and severity of diabetes on Na,K-ATPase activity and arachidonoyl-containing glycerophospholipid molecular species in nerve from streptozotocin diabetic rats. J Peripher Nerv Syst 2:155-63
Eichberg, J; Iyer, S (1996) Phosphorylation of myelin protein: recent advances. Neurochem Res 21:527-35
Eichberg, J; Sheldon, R; Kuruvilla, R et al. (1996) Receptor-mediated phosphoinositide metabolism in peripheral nerve and cultured Schwann cells. J Lipid Mediat Cell Signal 14:187-95

Showing the most recent 10 out of 45 publications